3 Suppliers
0 Customers
3 Debt Items
17 Related Chains
Search LONA in the supply chain database
Create LONA supply chain alerts
Read LONA supply chain intel
ORANGE supply chain
NVIDIA Corporation supply chain
Amazon.com, Inc. supply chain
Johnson & Johnson supply chain
Suppliers 3
Clients 0
Debt 3
Acquisitions 0
Ownership 1
Secondary 17
LeonaBio, Inc. Suppliers
Ticker Name Confidence Evidence
SERMONIX
SERMONIX
92%
As consideration for the rights granted to the Company under the Sermonix License Agreement entered into between the Company and Sermonix on December 18, 2025, the Company issued to Sermonix the Serm…
SHANGHAI-HENLIUS-BIOTECH-INC
SHANGHAI-HENLIUS-BIOTECH-INC
85%
the Company is coordinating with Sermonix and Shanghai Henlius Biotech, Inc. (“ Henlius ”), Sermonix’s exclusive licensee for oral lasofoxifene in Asia and certain countries in the Middle East
LIGAND
LIGAND
80%
we entered into a direct license agreement with Ligand (the "Ligand Agreement") to replace Sermonix's license from Ligand
LeonaBio, Inc. Customers
No clients on record No downstream customers found in our database for LeonaBio, Inc..
LeonaBio, Inc. Debt Obligations
Instrument Description Confidence Evidence
LONA-DEBT-10762
Warrants outstanding: 4579000
90%
xbrl warrant detail from xbrl 2025-12-31.
LONA-DEBT-10763
Xbrl Convertible
90%
xbrl convertible detail from xbrl 2020-12-31.
LONA-DEBT
Debt stack $691,000
90%
Market cache reports total debt of $691,000.
LeonaBio, Inc. Acquisitions
No acquisitions on record No completed or pending acquisitions found in our database for LeonaBio, Inc..
LeonaBio, Inc. Ownership
Holder Name Confidence Evidence
LONA-OWNER-PERCEPTIVE-ADVISORS-LLC
PERCEPTIVE ADVISORS LLC
90%
13F overlay lists PERCEPTIVE ADVISORS LLC as top holder; 40 tracked holders.
LeonaBio, Inc. Extended Supply Chain Network
Ticker Name Chain Index Hops Relationship Types
OVID
Ovid Therapeutics Inc.
100.00
2
VKTX
Viking Therapeutics, Inc.
100.00
2
ELUT
Elutia Inc.
100.00
2
SGMO
Sangamo Therapeutics, Inc.
100.00
2
PLX
Protalix BioTherapeutics, Inc.
100.00
2
OBIO
Orchestra BioMed Holdings, Inc.
100.00
2
CRMD
CorMedix Inc.
100.00
2
AGEN
Agenus Inc.
100.00
2
OABIW
OmniAb, Inc.
50.00
2
XOMA
XOMA Royalty Corporation
50.00
2
DNTH
Dianthus Therapeutics, Inc.
50.00
2
XOMAP
XOMA Royalty Corporation
50.00
2
LGND
Ligand Pharmaceuticals Incorporated
38.88
1
['receiving']
RYLAZE
RYLAZE
23.09
2
LLY
Eli Lilly and Company
14.78
2
PVLA
Palvella Therapeutics, Inc.
14.78
2
SNYNF
Sanofi
14.78
2